Journal of Commercial Biotechnology - IssueJournal of Commercial Biotechnology is the definitive international quarterly publication for bioscience business professionals.
http://www.palgrave-journals.com/jcb/current_issue/
Palgrave Macmillan LtdenJournal of Commercial Biotechnology1462-8732rights@palgrave.comJournal of Commercial Biotechnologyhttp://www.palgrave-journals.com/pal/images/logos_b_o_w/jcb.gif
http://www.palgrave-journals.com/jcb/
Exciting changes
http://feeds.palgrave-journals.com/~r/jcb/rss/current/~3/OtMUDyneY7o/jcb.2011.29
]]>Exciting changesYali Friedmandoi:10.1057/jcb.2011.29Journal of Commercial Biotechnology 17, 289 (November 2011)Journal of Commercial Biotechnologyhttp://dx.doi.org/10.1057/jcb.2011.29New technologies for neglected diseases: Can tax credits help biotechnology companies advance global health?
http://feeds.palgrave-journals.com/~r/jcb/rss/current/~3/czzZSX38i00/jcb.2011.27
]]>New technologies for neglected diseases: Can tax credits help biotechnology companies advance global health?Aarthi Raodoi:10.1057/jcb.2011.27Journal of Commercial Biotechnology 17, 290 (November 2011)September 27, 2011Journal of Commercial BiotechnologySeptember 27, 2011http://dx.doi.org/10.1057/jcb.2011.27Biotechnology commercialisation in universities of developing countries: A review of the University of Ibadan, Nigeria
http://feeds.palgrave-journals.com/~r/jcb/rss/current/~3/pot6zky9Blc/jcb.2011.28
]]>Biotechnology commercialisation in universities of developing countries: A review of the University of Ibadan, NigeriaChimdiya Julian Onyekadoi:10.1057/jcb.2011.28Journal of Commercial Biotechnology 17, 293 (November 2011)Journal of Commercial Biotechnologyhttp://dx.doi.org/10.1057/jcb.2011.28Innovation in R&D: Using design thinking to develop new models of inventiveness, productivity and collaboration
http://feeds.palgrave-journals.com/~r/jcb/rss/current/~3/CQTyAoBG_Q4/jcb.2011.25
]]>Innovation in R&D: Using design thinking to develop new models of inventiveness, productivity and collaborationinnovationcollaborationproductivityresearch and developmentdesign thinkingTad SimonsArvind GuptaMary Buchanandoi:10.1057/jcb.2011.25Journal of Commercial Biotechnology 17, 301 (November 2011)August 23, 2011Journal of Commercial BiotechnologyAugust 23, 2011http://dx.doi.org/10.1057/jcb.2011.25The strength of pharmaceutical IPRs vis-à-vis foreign direct investment in clinical research: Preliminary findings
http://feeds.palgrave-journals.com/~r/jcb/rss/current/~3/obHvht7hjFQ/jcb.2011.23
]]>The strength of pharmaceutical IPRs vis-à-vis foreign direct investment in clinical research: Preliminary findingsclinical trialforeign direct investmentintellectual property rightspharmaceuticaldeveloping countryMeir Perez PugatchRachel Chudoi:10.1057/jcb.2011.23Journal of Commercial Biotechnology 17, 308 (November 2011)August 16, 2011Journal of Commercial BiotechnologyAugust 16, 2011http://dx.doi.org/10.1057/jcb.2011.23Some considerations for the implementation of disposable technology and single-use systems in biopharmaceuticals
http://feeds.palgrave-journals.com/~r/jcb/rss/current/~3/31K9SV_SLNQ/jcb.2011.21
]]>Some considerations for the implementation of disposable technology and single-use systems in biopharmaceuticalssingle-use sterile disposable technologysterility assuranceaseptic processingcontamination controlirradiationmicrobiologyTim SandleMadhu Raju Sagheedoi:10.1057/jcb.2011.21Journal of Commercial Biotechnology 17, 319 (November 2011)August 2, 2011Journal of Commercial BiotechnologyAugust 2, 2011http://dx.doi.org/10.1057/jcb.2011.21Catalyzing capital for Canada's life sciences industry
http://feeds.palgrave-journals.com/~r/jcb/rss/current/~3/FE6srh5Yy_U/jcb.2011.26
]]>Catalyzing capital for Canada's life sciences industryventure capitalpolicyCanadabiotechnologyreturns on investmentfinanceJoseph TuckerJustin ChakmaPaul WM FedakMassimo Ciminidoi:10.1057/jcb.2011.26Journal of Commercial Biotechnology 17, 330 (November 2011)Journal of Commercial Biotechnologyhttp://dx.doi.org/10.1057/jcb.2011.26Academic entrepreneurship, entrepreneurial universities and biotechnology
http://feeds.palgrave-journals.com/~r/jcb/rss/current/~3/Lc8PtvNTWv0/jcb.2011.22
]]>Academic entrepreneurship, entrepreneurial universities and biotechnologyentrepreneurialentrepreneurshipuniversitybioentrepreneurshiptechnology transferknowledge exchangeArlen D MeyersSarika Pruthidoi:10.1057/jcb.2011.22Journal of Commercial Biotechnology 17, 349 (November 2011)Journal of Commercial Biotechnologyhttp://dx.doi.org/10.1057/jcb.2011.22Patent strategies for life sciences companies to navigate the changing patent landscape
http://feeds.palgrave-journals.com/~r/jcb/rss/current/~3/s19Ez7aPnFc/jcb.2011.30
]]>Patent strategies for life sciences companies to navigate the changing patent landscapeDavid J DykemanDanielle T Abramsondoi:10.1057/jcb.2011.30Journal of Commercial Biotechnology 17, 358 (November 2011)Journal of Commercial Biotechnologyhttp://dx.doi.org/10.1057/jcb.2011.30FDA at BIO 2011 – Weighing a hefty mission: Where is the balance?
http://feeds.palgrave-journals.com/~r/jcb/rss/current/~3/UL4Cz1S_T9A/jcb.2011.24
]]>FDA at BIO 2011 – Weighing a hefty mission: Where is the balance?Suzanne Levydoi:10.1057/jcb.2011.24Journal of Commercial Biotechnology 17, 365 (November 2011)September 6, 2011Journal of Commercial BiotechnologySeptember 6, 2011http://dx.doi.org/10.1057/jcb.2011.24